Trial intelligence / Profile preview

Ciprofol vs propofol for drug-induced sleep endoscopy in OSAHS

ChiCTR2500115600Phase 4Recruiting

Sponsor
Xiangya Hospital, Central South University
Start
Dec 2025
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ciprofol in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: Time-weighted average of hypoxemia and Sedation success rate. Started Dec 2025; status: recruiting.

02

Drugs

ciprofol
03

Conditions

obstructive sleep apnea hypopnea syndrome (OSAHS)

Beyond the preview

Go deeper on ChiCTR2500115600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500115600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call